Osteocalcin, energy and glucose metabolism;Osteocalcina, metabolismo energético e da glicose

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 58, Issue 5, 2014, Pages 444-451

  Zanatta, Leila C B ^a   Boguszewski, Cesar L ^a   Borba, Victoria Z C ^a   Kulak, Carolina A M ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Adiponectin; Diabetes; Energy metabolism; Glucose; Insulin; Leptin; Metabolic syndrome; Obesity; Osteocalcin; Undercarboxylated osteocalcin

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; OSTEOCALCIN;

ADIPOSE TISSUE; ANIMAL; BLOOD; BONE; DRUG EFFECTS; ENERGY METABOLISM; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; BONE AND BONES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LEPTIN; METABOLIC SYNDROME X; MUSCLES; OBESITY; OSTEOCALCIN;

EID: 84906701479     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/0004-2730000003333     Document Type: Review

References (50)

1. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-defcient mice. Nature. 1996;382:448-452.
2. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-469.
3. Jackson MB, Ahima RS. Neuroendocrine and metabolic effects of adipocyte-derived hormones. Clin Sci (Lond). 2006;110(2):143-152.
4. Ducy P, Amling M, Takeda S, Priemel M, Schilling A F, Beil F T, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100:197-207.
5. Karsenty G. Convergence between bone and energy homeos-tases: leptin regulation of bone mass. Cell Metab. 2006;4:341-348.
6. Karsenty G, Oury F. The central regulation of bone mass, the frst link between bone remodeling and energy metabolism. J Clin Endocrinol Metab. 2010;95:4795-4801.
7. Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, Confavreux C, et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell. 2009;138:976-989.
8. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002;111:305-317.
9. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev. 1989;69:990-1047.
10. Cancela L, Hsieh CL, Francke U, Price PA. Molecular structure, cromosome assignment and promoter organization of the human matrix Gla protein gene. J Biol Chem. 1990;265(25):15040-15048.
11. Engelke JA, Hale JE, Suttie JW, Price PA. Vitamin K-dependent carboxylase: utilization of decarboxylated bone Gla protein and matrix Gla protein as substrates. Biochim Biophys Acta. 1991;1078:31-34.
12. Price PA. Gla-containing proteins of bone. Connect Tissue Res. 1989;21:51-57, discussion 57-60.
13. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta-cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad. Sci. U.S.A. 2008;105:5266-5270.
14. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-754.
15. Lee K, Nichols J, Smith A. Identification of a developmentally regulated protein tyrosine phosphatase in embryonic stem cells that is a marker of pluripotential epiblast and early me-soderm. Mech Dev. 1996;59:153-164.
16. Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, Davis AR, Dixon JE. Identifcation of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem. 1994;269:30659-30667.
17. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142(2):296-308.
18. Yoshizawa T, Hinoi E, Jung DY, Kajimura D, Ferron M, Seo J, et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest. 2009;119:2807-2817.
19. Teitelbaum SL, Ross F P. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4(8):638-649.
20. Harada S, Takahashi N. Control of bone resorption by RANKL -RANK system. Clin Calcium. 2011;21(8):1121-1130.
21. Wellendorph P, Brauner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene. 2004;335:37-46.
22. Pi M, Chen L, Huang MZ, Zhu W, Ringhofer B, Luo J, et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One. 2008;3(12):e3858.
23. Pi M, Yunpeng Wu Y, Quarles LD. GPRC6A mediates responses to osteocalcin in b-cells in vitro and pancreas in vivo. J Bone Miner Res. 2011;26(7):1680-1683.
24. Im JA, Yu B P, Jeon J Y, Kim SH. Relationship between osteocal-cin and glucose metabolism in postmenopausal women. Clin Chim Acta. 2008;396(1-2):66-69.
25. Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24:785-791.
26. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:827-883.
27. Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Beilby J P, et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol. 2010;163(2):265-272.
28. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94:45-49.
29. Goliasch G, Blessberger H, Azar D, Heinze G, Wojta J, Biegl-mayer C, et al. Markers of bone metabolism in premature myocardial infarction (≤ 40 years of age). Bone. 2010;48:622-626.
30. Zhou M, Ma X, Li H, Pan X, Tang J, Gao Y, et al. Serum osteocal-cin concentration in relation to glucose and lipid metabolism in Chinese individual. Eur J Endocrinol. 2009;161(5):723-729.
31. García-Martín A, Cortés-Berdonces M, Luque-Fernández I, Ro-zas-Moreno P, Quesada-Charneco M, Muñoz-Torres M. Osteo-calcin as a marker of metabolic risk in healthy postmenopau-sal women. Menopause. 2011;18(5):537-541.
32. Fernández-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gó-mez-Ambrosi J, Moreno-Navarrete JM, et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitive and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab. 2009;94:237-245.
33. Saleem U, Mosley Jr TH, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol. 2010;30(7):1474-1478.
34. Bao Y, Ma X, Yang R, Wang F, Hao Y, Dou J, et al. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J Clin Endocrinol Metab. 2013;98:345-351.
35. Winhofer Y, Handisurya A, Tura A, Bittighofer C, Klein K, Schneider B, et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care. 2010;33:139-143.
36. Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev. 2009;25:768-772.
37. Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int. 2011;22:187-194.
38. Yoshida M, Jacques P F, Meigs JB, Saltzman E, Shea MK, Gundberg C, et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care. 2008;31:2092-2096.
39. Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, et al. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr. 2009;90:1230-1235.
40. Kumar R, Binkley N, Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr. 2010;92:1528-1532.
41. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specifc immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab. 1997;82:719-724.
42. Nimptsch K, Hailer S, Rohrmann S, Gedrich K, Wolfram G, Lin-seisen J. Determinants and correlates of serum undercarbo-xylated osteocalcin. Ann Nutr Metab. 2007;51:563-570.
43. Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med. 2009;218:201-205.
44. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, et al. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adi-ponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab. 2011;96(12):E1982-E1989.
45. Levinger I, Zebaze R, Jerums G, Hare DL, Selig S, Seeman E. The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporos Int. 2011;22:1621-1626.
46. Pollock NK, Bernard PJ, Wenger K, Misra S, Gower BA, Allison JD, et al. Lower bone mass in prepubertal overweight children with prediabetes. J Bone Miner Res. 2010;25(12):2484-2493.
47. Pollock NK, Bernard PJ, Gower BA, Gundberg CM, Wenger K, Misra S. Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function. J Clin Endocrinol Metab. 2011;96:1092-1099.
48. Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond). 2010;34:852-858.
49. Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetolo-gia. 2011;54:1291-1297.
50. Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res. 2011;26(4):677-680.